Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESERT: Acoltremon in Real World Treatment for Dry Eye Disease
NCT07281950Phase 4Not yet recruiting
- Sponsor
- Center For Sight
- Start
- Dec 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acoltremon in dry eye disease (DED), sponsored by Center For Sight. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
acoltremon
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07281950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07281950.